First Participant Dosed in Tisento Therapeutics’ Global Phase 2b PRIZM Study Evaluating Zagociguat for the Treatment of MELAS
Patient-Centered PRIZM Study Measures Impact of Once-Daily Oral Zagociguat on Fatigue and Cognitive Impairment, Hallmark Features of this Rare Mitochondrial DiseaseCAMBRIDGE, Mass., Jan. 27, 2025 ...
Insurancenewsnet.com2h
Proxy Statement (Form DEF 14A)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14 A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14 A INFORMATION Proxy Statement Pursuant to Section 14 of the ...
SHINE8h
From smokestacks to smart solutions: Shibei's evolution as an innovation hub
What Aviles describes is the result of more than three decades of transformation. Once an industrial wasteland dominated by ...
Will Donald Trump reveal the names on the Epstein list?
President Donald Trump faces growing calls to unseal the documents surrounding Jeffrey Epstein's controversial death. Tennessee Republicans Sen. Marsha Blackburn and Rep. Tim Bur ...